1h Free Analyst Time
The pharmacovigilance market is forecasted to grow by USD 2.87 billion during 2023-2028, accelerating at a CAGR of 5.8% during the forecast period. The report on the pharmacovigilance market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing number of clinical trials.
The pharmacovigilance market is segmented as below:
By Service
- In-house
- Contract outsourcing
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the pharmacovigilance market covers the following areas:
- Pharmacovigilance Market sizing
- Pharmacovigilance Market forecast
- Pharmacovigilance Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global pharmacovigilance market: Accenture PLC, ArisGlobal LLC, Capgemini Services SAS, ClinChoice, Cognizant Technology Solutions Corp., eResearchTechnology GmbH, ICON plc, International Business Machines Corp., IQVIA Holdings Inc., ITClinical, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Parexel International Corp., SIRO Clinpharm Pvt. Ltd., Symogen Ltd., TAKE Solutions Ltd., Thermo Fisher Scientific Inc., United BioSource LLC, and Wipro Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising outsourcing of pharmacovigilance to cros."
According to the report, one of the major drivers for this market is the rising incidence rates of adverse drug events.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accenture PLC
- ArisGlobal LLC
- Capgemini Services SAS
- ClinChoice
- Cognizant Technology Solutions Corp.
- eResearchTechnology GmbH
- ICON plc
- International Business Machines Corp.
- IQVIA Holdings Inc.
- ITClinical
- Laboratory Corp. of America Holdings
- Linical Co. Ltd.
- Medpace Holdings Inc.
- Parexel International Corp.
- SIRO Clinpharm Pvt. Ltd.
- Symogen Ltd.
- TAKE Solutions Ltd.
- Thermo Fisher Scientific Inc.
- United BioSource LLC
- Wipro Ltd.
